ARTICLE | Clinical News
Epivir lamivudine 3TC nucleoside analog regulatory update
February 5, 2001 8:00 AM UTC
BioChem Pharma Inc. (BCHE; TSE:BCH), Laval, Quebec Product: Epivir lamivudine 3TC nucleoside analog Business: Infectious diseases BCHE received U.S. Patent No. 6,180,639 covering the combination of E...